New research suggests areas with higher concentrations of microplastics also have higher rates of chronic disease.
Communities exposed to higher concentrations of microplastic pollution also experience higher rates of chronic noncommunicable diseases (NCDs), including hypertension, diabetes, and stroke, according to new research to be presented at the American College of Cardiology Annual Scientific Session (ACC.25).1
The latest findings add to research on how environmental pollution may be contributing to the country’s growing burden of cardiovascular disease (CVD). Over the past year alone, experts have talked to The American Journal of Managed Care® (AJMC®) about a number of environmental risk factors impacting Americans, from climate change to the California wildfires.2,3
Prior research has also found a causal relationship between air pollutants and increased CVD risk, highlighting the need for protective measures to mitigate exposure.4 Another study looking at ambient air respiratory toxins in US public schools found that more children of Latino, Hispanic, and Asian descent were disabled after being exposed to these noncancerous toxins in schools with the highest potential exposure risk.5
Microplastics are plastic fragments measuring between 1 nanometer and 5 millimeters; they are released when larger plastics degrade.1 Exposure occurs when people ingest or inhale these particles, which are now widespread in drinking water, food, and the air.
Areas with higher concentrations of microplastics also had higher rates of noncommunicable diseases. | Image credit: © Microgen – stock.adobe.com
In the newest study, researchers from Case Western Reserve School of Medicine examined 555 US census tracts located within 200 meters of large bodies of water, where microplastics concentration data are more reliably available. They merged this environmental data with disease prevalence statistics from the CDC PLACES database and 154 additional socioeconomic and environmental factors, including income, employment, social vulnerability, and air pollution.
The researchers found that areas with more microplastic pollution showed a strong association with NCDs across US coastal regions, with positive correlations between microplastic concentration and rates of high blood pressure (correlation coefficient r = 0.24), diabetes (r = 0.3), and stroke (r = 0.26).6 Interestingly, cancer rates had a negative correlation (ˆ = –0.16).
These correlations held up under additional analysis of variance, which showed statistically significant differences in NCD prevalence based on levels of microplastic exposure, this time with an association between microplastic concentration and cancer risk. Researchers also used a machine learning model called XGBoost to predict disease prevalence and assess the relative importance of each variable. Microplastic concentration emerged as a top contributor, particularly in predicting stroke prevalence.
“This study provides initial evidence that microplastics exposure has an impact on cardiovascular health, especially chronic, noncommunicable conditions like high blood pressure, diabetes, and stroke,” said Sai Rahul Ponnana, MA, research data scientist at Case Western Reserve School of Medicine in Ohio and lead author of the study.1 “When we included 154 different socioeconomic and environmental features in our analysis, we didn’t expect microplastics to rank in the top 10 for predicting chronic noncommunicable disease prevalence.”
The researchers stressed that although their findings are concerning, they do not yet prove a causal relationship. However, the patterns observed warrant further investigation, especially into the amount of time or exposure it takes for microplastics to impact a person’s health. In the meantime, based on current evidence, Ponnana said it’s important to limit exposure.
“While it is not feasible to completely avoid ingesting or inhaling microplastics when they are present in the environment, given how ubiquitous and tiny they are," the press release said, "the best way to minimize microplastics exposure is to curtail the amount of plastic produced and used, and to ensure proper disposal,”
References
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Healing Wounds Through Peer Support
September 16th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
Listen
High Drug Costs, PBM Reform, and Access Challenges Take Center Stage at AMCP 2025
March 25th 2025As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, the upcoming AMCP annual meeting will provide critical insights into legislative impacts, drug affordability, formulary design, and emerging treatment trends.
Read More